Solstice Neurosciences, Llc, A Subsidiary Of Mdd Us Operations, Llc
Clinical trials sponsored by Solstice Neurosciences, Llc, A Subsidiary Of Mdd Us Operations, Llc, explained in plain language.
-
Botulinum injection trial for arm spasticity halted early
Disease control TerminatedThis study tested whether injections of MYOBLOC (botulinum toxin type B) can safely reduce muscle tightness in the arm and hand of adults with spasticity caused by stroke, brain injury, multiple sclerosis, or other conditions. The trial planned to enroll about 300 participants bu…
Phase: PHASE2, PHASE3 • Sponsor: Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Botulinum toxin injection aimed at easing leg spasticity after stroke or injury
Symptom relief TerminatedThis study tested whether MYOBLOC, a botulinum toxin injection, can safely reduce muscle stiffness in the lower leg of adults with spasticity caused by stroke, brain injury, or spinal cord injury. About 40 participants received either a low or high dose of MYOBLOC or a placebo in…
Phase: PHASE2, PHASE3 • Sponsor: Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC